Q4 2025 Hinge Health Inc Earnings Call Transcript

Feb 10, 2026 / 09:30 PM GMT

Release Date Price: $33.05 (+2.77%)

Transcript 8-K

Key Points

Positve

Hinge Health Inc (HNGE) reported a 46% year-over-year revenue growth for Q4 2025, reaching $171 million.
The company achieved a gross margin of 85% in Q4, showcasing the scalability of its technology-driven care model.
Hinge Health Inc (HNGE) generated $62 million in free cash flow in Q4, representing a free cash flow margin of 36%.
The company expanded its market reach to nearly 25 million contracted lives, demonstrating strong commercial momentum.
Hinge Health Inc (HNGE) introduced AI-powered tools that improved care delivery efficiency, allowing the company to serve 47% more members while keeping care team costs flat.

Negative

Despite the positive financial performance, the company faces potential threats from new entrants in the market, including large tech companies and startups.
Hinge Health Inc (HNGE) anticipates no significant revenue impact from its Hinge Select product until at least 2027.
The company is investing heavily in expanding its provider network, which may take several years to build and scale.
There is uncertainty regarding the pricing structure of the CMS Access program, which could impact future revenue from the Medicare population.
Hinge Health Inc (HNGE) is assuming flat yield in its 2026 forecast, indicating potential challenges in driving further engagement improvements.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HNGE.N - Hinge Health Inc
Q4 2025 Hinge Health Inc Earnings Call
Feb 10, 2026 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for joining us and welcome to the Hinge Health 4th quarter 2025 earnings call. After today's prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please raise your hand. If you have dialed in today's call, please press 9 to raise your hand and 6 to unmute. I will now hand the conference over to Bianca Buck, head of investor relations. Bianca, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon and welcome to Hinge Health's 4th quarter and full year 2025 earnings call. I'm Bianca Buck,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.